An Extended Terminal Half-Life for Darbepoetin AlfaResults from a Single-Dose Pharmacokinetic Study in Patients with Chronic Kidney Disease not Receiving Dialysis

被引:0
|
作者
Desmond Padhi
Liyun Ni
Blaire Cooke
Rafael Marino
Graham Jang
机构
[1] Amgen Inc.,
来源
Clinical Pharmacokinetics | 2006年 / 45卷
关键词
Chronic Kidney Disease; Darbepoetin Alfa; Endogenous Erythropoietin; Single Subcutaneous Dose; Erythropoietic Agent;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:503 / 510
页数:7
相关论文
共 50 条
  • [31] Quality of Life of Patients with Chronic Kidney Disease: A Comparative Study between Nondialysis and Dialysis Patients
    Almutary, Hayfa
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (04) : 949 - 956
  • [32] Quality of Life in Patients with Chronic Kidney Disease Managed with or without Dialysis: An Observational Study
    So, Sarah
    Li, Kelly
    Hoffman, Anna T.
    Josland, Elizabeth
    Brown, Mark A.
    KIDNEY360, 2022, 3 (11): : 1890 - 1898
  • [33] DARBEPOETIN ALFA, ONCE MONTHLY DOSING, CORRECTS ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS: A RANDOMIZED PHASE III STUDY
    Ferenczi, Sandor
    Roger, Simon
    Malecki, Robert
    Farouk, Mourad
    Dellanna, Frank
    Thomas, Mark
    Manamley, Nick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 364 - 364
  • [34] ANOPEN-LABEL, SINGLE-DOSE STUDY TOEVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CINACALCET IN PEDIATRIC SUBJECTS AGED 28 DAYS TO < 6 YEARS WITH CHRONIC KIDNEY DISEASE RECEIVING DIALYSIS
    Warady, Bradley
    Portale, Anthony
    Zhang, Hao
    Yan, Lucy
    Ertik, Bella
    Lee, Edward
    Shahinfar, Shahnaz
    Dehmel, Bastian
    Sohn, Winnie
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1715 - 1715
  • [35] Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis
    Winnie Y. Sohn
    Anthony A. Portale
    Isidro B. Salusky
    Hao Zhang
    Lucy L. Yan
    Bella Ertik
    Shahnaz Shahinfar
    Edward Lee
    Bastian Dehmel
    Bradley A. Warady
    Pediatric Nephrology, 2019, 34 : 739 - 740
  • [36] Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
    Alexander Solms
    Anita Shah
    Erik Berntorp
    Andreas Tiede
    Alfonso Iorio
    Camila Linardi
    Maurice Ahsman
    Maria Elisa Mancuso
    Tihomir Zhivkov
    Toshko Lissitchkov
    Annals of Hematology, 2020, 99 : 2689 - 2698
  • [37] A multicenter, single-arm study of roxadustat in Chinese patients with chronic kidney disease-associated anemia receiving peritoneal dialysis
    Yu, Xueqing
    Ye, Zhiming
    Wu, Yiqing
    Huang, Cuihua
    Pan, Shuting
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2355 - I2356
  • [38] A multicenter, single-arm study of roxadustat in Chinese patients with chronic kidney disease-associated anemia receiving peritoneal dialysis
    Yu, Xueqing
    Ye, Zhiming
    Wu, Yiqing
    Huang, Cuihua
    Pan, Shuting
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [39] Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
    Solms, Alexander
    Shah, Anita
    Berntorp, Erik
    Tiede, Andreas
    Iorio, Alfonso
    Linardi, Camila
    Ahsman, Maurice
    Mancuso, Maria Elisa
    Zhivkov, Tihomir
    Lissitchkov, Toshko
    ANNALS OF HEMATOLOGY, 2020, 99 (11) : 2689 - 2698
  • [40] OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Lunde, Martin
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    Senbetta, Mekre
    McKenzie, R. Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A60 - A60